Law360, New York (July 14, 2006) -- A federal judge has upheld Forest Laboratories Inc.’s patent on the blockbuster antidepressant drug Lexapro, thwarting Ivax Pharmaceuticals Corp.’s plans to market a generic.
In an opinion issued Thursday in the U.S. District Court in Delaware, Judge Joseph Farnan, Jr. rejected Ivax’s argument that the patent was anticipated, obvious and impermissibly broadened upon reissue....
